China Pharma Holdings Inc. (AMEX: CPHI) started the day on November 23, 2022, with a price increase of 3.25% at $0.10. During the day, the stock rose to $0.11 and sunk to $0.10 before settling in for the price of $0.10 at the close. Taking a more long-term approach, CPHI posted a 52-week range of $0.09-$0.67.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -9.10%. Meanwhile, its Annual Earning per share during the time was 19.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -12.10%. This publicly-traded company’s shares outstanding now amounts to $50.02 million, simultaneously with a float of $23.52 million. The organization now has a market capitalization sitting at $5.93 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1313, while the 200-day Moving Average is $0.2455.
While finding the extent of efficiency of the company that is accounted for 236 employees. For the Profitability, stocks gross margin was +3.23, operating margin was -29.67 and Pretax Margin of -35.26.
China Pharma Holdings Inc. (CPHI) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. China Pharma Holdings Inc.’s current insider ownership accounts for 54.45%, in contrast to 1.20% institutional ownership.
China Pharma Holdings Inc. (CPHI) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2011, the organization reported $0.08 earnings per share (EPS) for the three months, lower than the consensus estimate (set at $0.12) by -$0.04. This company achieved a net margin of -35.26 while generating a return on equity of -48.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
China Pharma Holdings Inc.’s EPS decrease for this current 12-month fiscal period is -12.10%. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.00% through the next 5 years, which can be compared against the 19.00% growth it accomplished over the previous five years trading on the market.
China Pharma Holdings Inc. (AMEX: CPHI) Trading Performance Indicators
Let’s observe the current performance indicators for China Pharma Holdings Inc. (CPHI). It’s Quick Ratio in the last reported quarter now stands at 0.20. The Stock has managed to achieve an average true range (ATR) of 0.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.73.
In the same vein, CPHI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.08.
Technical Analysis of China Pharma Holdings Inc. (CPHI)
If we take a close look at the recent performances of China Pharma Holdings Inc. (AMEX: CPHI), its last 5-days Average volume was 0.22 million that shows plunge from its year to date volume of 0.23 million. During the previous 9 days, stock’s Stochastic %D was recorded 28.29% While, its Average True Range was 0.0120.